The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Hotjar and Clarity help us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
email:
Alice.Seywright.2@glasgow.ac.uk
School of Medicine, Dentistry & Nursing, Forensic Medicine & Science, Level A2, Joseph Black Building, Gilmorehill Campus
Seywright, A., Irvine, A. F. D., Mckeown, D. A., Wylie, F. M. and Torrance, H. J. (2022) Synthetic cannabinoid receptor agonists in postmortem casework in Scotland. Journal of Analytical Toxicology, (doi: 10.1093/jat/bkac002) (PMID:34994788)
Seywright, A., Torrance, H. J. , Wylie, F. M., Mckeown, D. A., Lowe, D. J. and Stevenson, R. (2016) Analysis and clinical findings of cases positive for the novel synthetic cannabinoid receptor agonist MDMB-CHMICA. Clinical Toxicology, 54(8), pp. 632-637. (doi: 10.1080/15563650.2016.1186805) (PMID:27213960)
Seywright, A., Irvine, A. F. D., Mckeown, D. A., Wylie, F. M. and Torrance, H. J. (2022) Synthetic cannabinoid receptor agonists in postmortem casework in Scotland. Journal of Analytical Toxicology, (doi: 10.1093/jat/bkac002) (PMID:34994788)
Seywright, A., Torrance, H. J. , Wylie, F. M., Mckeown, D. A., Lowe, D. J. and Stevenson, R. (2016) Analysis and clinical findings of cases positive for the novel synthetic cannabinoid receptor agonist MDMB-CHMICA. Clinical Toxicology, 54(8), pp. 632-637. (doi: 10.1080/15563650.2016.1186805) (PMID:27213960)